Xiaoxiao Zheng

机构：Peking University, China National Pharmaceutical Group Corporation (China), Tongde Hospital of Zhejiang Province, Zhejiang Cancer Hospital, Institute of Vegetables and Flowers, Peking University People's Hospital, Ministry of Agriculture, Chinese Academy of Agricultural Sciences, Hangzhou Hospital of Traditional Chinese Medicine, Huzhou Women and Children's Hospital, Qilu Hospital of Shandong University, Jiangxi Academy of Agricultural Sciences · ORCID：0000-0002-5275-1143

发表论文 77 篇 · 总被引 1507 次 · h-index 22

代表论文

• Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT (2023 · Cell Death and Disease · 被引 43)
• RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1 (2024 · Oncogene · 被引 28)
• METTL3 Potentiates M2 Macrophage‐Driven MMT to Aggravate Renal Allograft Fibrosis via the TGF‐β1/Smad3 Pathway (2025 · Advanced Science · 被引 20)
• Sini Decoction Inhibits Tumor Progression and Enhances the Anti-Tumor Immune Response in a Murine Model of Colon Cancer (2023 · Combinatorial Chemistry & High Throughput Screening · 被引 14)
• A retrospective pharmacovigilance study of post-marketing safety concerns with cefuroxime (2024 · Therapeutic Advances in Drug Safety · 被引 9)
• Diterpenoids with Schistosomula-Killing and Anti-Fibrosis Activities In Vitro from the Leaves of Croton tiglium (2024 · Molecules · 被引 3)